C. Archili

Randomized Study with the Pineal Hormone Melatonin versus Supportive Care Alone in Advanced Nonsmall Cell Lung Cancer Resistant to a First-Line Chemotherapy Containing Cisplatin

Paolo Lissoni, Sandro Barni, A. Ardizzoia et al. · Oncology · 2009 · 62 citations

Medicine, Oncology, Pharmacology +17

Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer patients resistant to interferon-alpha

Paolo Lissoni, Sandro Barni, Antonio Ardizzoia et al. · European Journal of Cancer · 1992 · 57 citations

Medicine, Immunology, Oncology +16

Activation of the Complement System during Immunotherapy of Cancer with Interleukin-2: A Possible Explanation of the Capillary Leak Syndrome

P. Lissoni, S. Barni, C. Archili et al. · The International Journal of Biological Markers · 1990 · 32 citations · Full text

Life Sciences, Immunology, Oncology +17

Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancer.

P. Lissoni, Sandro Barni, C. Archili et al. · PubMed · 1990 · 29 citations

Medicine, Endocrinology, Oncology +14

Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension.

Paolo Lissoni, F Brivio, Sandro Barni et al. · PubMed · 1991 · 26 citations

Life Sciences, Immunology, Oncology +17